Answers are grounded in this paper and cite their sources.
Neurofibromatosis type 1 is the most frequent phacomytosis. Patients with neurofibromatosis type 1 (NF1) have a high risk to develop benign or malignant tumors of neurogenic or non-neurogenic origin. The association of (NF1) to low-grade fibromyxoid sarcoma (LGFMS) is very rare. These tumors rarely develop at the skull and have a high incidence of local recurrence and distant metastasis. We report a case of occipital LGFMS in a patient diagnosed with NF1that developed a local and metastatic recurrence.
No takes yet. Share an insight, caveat, or question.
Bounniyt et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: